Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4.

To understand the molecular basis of granule release from platelets, we examined the role of vesicle-associated membrane protein, SNAP-23, and syntaxin 4 in alpha-granule secretion. A vesicle-associated membrane protein, SNAP-23, and syntaxin 4 were detected in platelet lysate. These proteins form a SDS-resistant complex that disassembles upon platelet activation. To determine whether these proteins are involved in alpha-granule secretion, we developed a streptolysin O-permeabilized platelet model of alpha-granule secretion. Streptolysin O-permeabilized platelets released alpha-granules, as measured by surface expression of P-selectin, in response to Ca2+ up to 120 min after permeabilization. Incubation of streptolysin O-permeabilized platelets with an antibody directed against vesicle-associated membrane protein completely inhibited Ca2+-induced alpha-granule release. Tetanus toxin cleaved platelet vesicle-associated membrane protein and inhibited Ca2+-induced alpha-granule secretion from streptolysin O-permeabilized platelets. An antibody to syntaxin 4 also inhibited Ca2+-induced alpha-granule release by approximately 75% in this system. These results show that vesicle-associated membrane protein, SNAP-23, and syntaxin 4 form a heterotrimeric complex in platelets that disassembles with activation and demonstrate that alpha-granule release is dependent on vesicle SNAP receptor-target SNAP receptor (vSNARE-tSNARE) interactions.

[1]  M K Bennett,et al.  Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. , 1997, Blood.

[2]  J. Pouysségur,et al.  A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. , 1993, The Journal of biological chemistry.

[3]  Reinhard Jahn,et al.  Vesicle fusion from yeast to man , 1994, Nature.

[4]  J. White,et al.  Effects of a microtubule stabilizing agent on the response of platelets to vincristine. , 1982, Blood.

[5]  R. Scheller,et al.  The syntaxin family of vesicular transport receptors , 1993, Cell.

[6]  R. Kelly,et al.  Effect of Mutations in Vesicle-Associated Membrane Protein (VAMP) on the Assembly of Multimeric Protein Complexes , 1997, The Journal of Neuroscience.

[7]  J. Foskett,et al.  Tetanus toxin light chain cleaves a vesicle-associated membrane protein (VAMP) isoform 2 in rat pancreatic zymogen granules and inhibits enzyme secretion. , 1994, The Journal of biological chemistry.

[8]  M. Linial.  SNARE Proteins‐Why So Many, Why So Few? , 1997, Journal of neurochemistry.

[9]  A. Fabiato,et al.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. , 1979, Journal de physiologie.

[10]  Peter Harrison,et al.  Platelet a-granules , 1993 .

[11]  B. Furie,et al.  Rapid phosphorylation and selective dephosphorylation of P-selectin accompanies platelet activation. , 1993, The Journal of biological chemistry.

[12]  V. Kakkar,et al.  Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion. , 1992, The Biochemical journal.

[13]  J. White,et al.  Role of actin in platelet function. , 1993, European journal of cell biology.

[14]  R. Scheller,et al.  Structural Organization of the Synaptic Exocytosis Core Complex , 1997, Neuron.

[15]  F. Benfenati,et al.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin , 1992, Nature.

[16]  P. Oh,et al.  Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including VAMP, NSF, SNAP, Annexins, and GTPases (*) , 1995, The Journal of Biological Chemistry.

[17]  J. White,et al.  Current concepts of platelet structure. , 1979, American journal of clinical pathology.

[18]  Jonathan Pevsner,et al.  Specificity and regulation of a synaptic vesicle docking complex , 1994, Neuron.

[19]  J. Marsal,et al.  Tetanus toxin inhibits spontaneous quantal release and cleaves VAMP/synaptobrevin , 1995, Brain Research.

[20]  T. Südhof,et al.  Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. , 1994, The EMBO journal.

[21]  R. Scheller,et al.  Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Mark K. Bennett,et al.  A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.

[23]  S. Grinstein,et al.  Subcellular distribution of docking/fusion proteins in neutrophils, secretory cells with multiple exocytic compartments. , 1995, Journal of immunology.

[24]  S. Seino,et al.  Localization and Functional Role of Synaptotagmin III in Insulin Secretory Vesicles in Pancreatic β-Cells , 1997, Diabetes.

[25]  L. Foster,et al.  Binary interactions of the SNARE proteins syntaxin-4, SNAP23, and VAMP-2 and their regulation by phosphorylation. , 1998, Biochemistry.

[26]  S. Wong,et al.  Identification of a vesicle-associated membrane protein (VAMP)-like membrane protein in zymogen granules of the rat exocrine pancreas. , 1994, The Journal of biological chemistry.

[27]  H. Takisawa,et al.  Anchorage of secretion-competent dense granules on the plasma membrane of bovine platelets in the absence of secretory stimulation , 1990, The Journal of cell biology.

[28]  Y. Mitsumoto,et al.  Expression of vesicle-associated membrane protein 2 (VAMP-2)/synaptobrevin II and cellubrevin in rat skeletal muscle and in a muscle cell line. , 1994, The Biochemical journal.

[29]  G. Lienhard,et al.  Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containing vesicles from rat adipocytes. , 1992, The Journal of biological chemistry.

[30]  P. Roche,et al.  Identification of a Novel Syntaxin- and Synaptobrevin/VAMP-binding Protein, SNAP-23, Expressed in Non-neuronal Tissues* , 1996, The Journal of Biological Chemistry.

[31]  T. Morimoto,et al.  ATP is required in platelet serotonin exocytosis for protein phosphorylation and priming of secretory vesicles docked on the plasma membrane. , 1996, Journal of cell science.

[32]  B. Chong,et al.  Plasma P-selectin is increased in thrombotic consumptive platelet disorders , 1994 .

[33]  T. Mayadas,et al.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice , 1993, Cell.

[34]  N. O. Dalby,et al.  Expression of VAMP-2-like protein in kidney collecting duct intracellular vesicles. Colocalization with Aquaporin-2 water channels. , 1995, The Journal of clinical investigation.

[35]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Martin,et al.  A novel 145 kd brain cytosolic protein reconstitutes Ca2+-regulated secretion in permeable neuroendocrine cells , 1992, Cell.

[37]  H. Patscheke,et al.  The exocytosis of human blood platelets. A fast freezing and freeze-substitution analysis. , 1987, European journal of cell biology.

[38]  J. Dolly,et al.  Botulinum A and the light chain of tetanus toxins inhibit distinct stages of Mg.ATP-dependent catecholamine exocytosis from permeabilised chromaffin cells. , 1994, European journal of biochemistry.

[39]  M. Scrutton,et al.  Ca2(+)-driven [3H]arachidonate release in electropermeabilized human platelets shows an absolute requirement for MgATP2-. , 1991, The Biochemical journal.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[41]  R. Rubin,et al.  Ethanol inhibits thrombin-induced secretion by human platelets at a site distinct from phospholipase C or protein kinase C. , 1990, The Biochemical journal.

[42]  L. Brass,et al.  Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. , 1992, The Journal of biological chemistry.

[43]  Paul Tempst,et al.  SNAP receptors implicated in vesicle targeting and fusion , 1993, Nature.

[44]  S. Grinstein,et al.  Characterization and subcellular localization of target membrane soluble NSF attachment protein receptors (t-SNAREs) in macrophages. Syntaxins 2, 3, and 4 are present on phagosomal membranes. , 1996, Journal of immunology.

[45]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[46]  J. White,et al.  Influence of a microtubule stabilizing agent on platelet structural physiology. , 1983, The American journal of pathology.

[47]  P. Lazo,et al.  Identification of two isoforms of the vesicle-membrane fusion protein SNAP-23 in human neutrophils and HL-60 cells. , 1997, Biochemical and biophysical research communications.

[48]  M. Shuman,et al.  A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation , 1985, The Journal of cell biology.

[49]  P. Hanson,et al.  Assembly and disassembly of a ternary complex of synaptobrevin, syntaxin, and SNAP-25 in the membrane of synaptic vesicles. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Scheller,et al.  VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues , 1996, The Journal of cell biology.

[51]  D. Aunis,et al.  Loss of proteins from digitonin-permeabilized adrenal chromaffin cells essential for exocytosis. , 1987, The Journal of biological chemistry.

[52]  J. White,et al.  The platelet open canalicular system: a final common pathway. , 1991, Blood cells.

[53]  T. Südhof,et al.  Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein , 1993, Nature.